Giulia Piomboni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Giulia Piomboni has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Anna Rita Bilia
Department of Chemistry Ugo Schiff, University of Florence, Via Ugo Schiff 6, Sesto Fiorentino, 50019 Florence, Italy
2 shared publications - Francesca Maestrelli
Department of Chemistry, School of Sciences of Human Health, University of Florence, via Schiff 6, Sesto Fiorentino, 50019 Florence, Italy
2 shared publications - Ilaria Chiarugi
Department of Chemistry "Ugo Schiff" (DICUS), University of Florence, Via Ugo Schiff 6, 50019 Florence, FI, Italy
2 shared publications - Sandra Ristori
University of Florence
2 shared publications
Latest Publications
- Open Access
- 21 February 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (2) , 265
Non-Viral Nanovectors Based on Cyclodextrins for siRNA Delivery: An Update to Current Technologies
Gene delivery/administration and, in particular, small interfering RNA (siRNA) delivery represent a therapeutic challenge, though very effective carriers have yet to be identified. Cyclodextrins (CDs) are cyclic oligosaccharides with unique host–guest inclusion capabilities, widely recognized in the pharmaceutical field for their ability to enhance drug solubility and bioavailability. Their excellent biocompatibility and chemical versatility make them powerful building blocks for the design of supramolecular nanovectors (NVs). Thanks to their facility of functionalization, CDs are highly versatile and have found numerous applications across various fields. In this context, CD-based NVs are currently explored as non-viral agents to transport and release siRNA. Recent studies suggest that self-assembled NVs based on CDs can improve the transfection and safety of siRNA delivery. This review provides a comprehensive overview of the most recent advances in the design of NVs based on CDs and their use for siRNA delivery, discussing the role played by structural differences and chemical functionalization in the context of encapsulation and release.
- 21 February 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (2) , 265
Open AccessNon-Viral Nanovectors Based on Cyclodextrins for siRNA Delivery: An Update to Current Technologies
Gene delivery/administration and, in particular, small interfering RNA (siRNA) delivery represent a therapeutic challenge, though very effective carriers have yet to be identified. Cyclodextrins (CDs) are cyclic oligosaccharides with unique host–guest inclusion capabilities, widely recognized in the pharmaceutical field for their ability to enhance drug solubility and bioavailability. Their excellent biocompatibility and chemical versatility make them powerful building blocks for the design of supramolecular nanovectors (NVs). Thanks to their facility of functionalization, CDs are highly versatile and have found numerous applications across various fields. In this context, CD-based NVs are currently explored as non-viral agents to transport and release siRNA. Recent studies suggest that self-assembled NVs based on CDs can improve the transfection and safety of siRNA delivery. This review provides a comprehensive overview of the most recent advances in the design of NVs based on CDs and their use for siRNA delivery, discussing the role played by structural differences and chemical functionalization in the context of encapsulation and release.
- Open Access
- 24 November 2025
- Published by MDPI AG in Preprints.org
Non-Viral Nanovectors Based on Cyclodextrins for siRNA Delivery: An Update to Current Technologies
Gene delivery/administration and, in particular, small interfering RNA (siRNA) delivery represents a therapeutic challenge and very effective carriers have yet to be identified. Cyclodextrins (CDs) are cyclic oligosaccharides with unique host–guest inclusion capabilities, widely recognized in the pharmaceutical field for their ability to enhance drug solubility and bioavailability. Their excellent biocompatibility and chemical ver-satility make them powerful building blocks for the design of supramolecular nano-vectors (NVs). Thanks to their facility of functionalization, CDs are highly versatile and have found numerous applications across various fields. In this contest CD based NVs are currently explored as non-viral agents to transport and release siRNA. Recent studies suggest that self-assembled NVs based on CDs can improve the transfection and safety of siRNA delivery systems. This review provides a comprehensive overview of the most recent advances in the design of NVs based on CDs and their use for delivery of siRNA, discussing the ins and outs of structural differences and chemical functionalization.
- 24 November 2025
- Published by MDPI AG in Preprints.org
Open AccessNon-Viral Nanovectors Based on Cyclodextrins for siRNA Delivery: An Update to Current Technologies
Gene delivery/administration and, in particular, small interfering RNA (siRNA) delivery represents a therapeutic challenge and very effective carriers have yet to be identified. Cyclodextrins (CDs) are cyclic oligosaccharides with unique host–guest inclusion capabilities, widely recognized in the pharmaceutical field for their ability to enhance drug solubility and bioavailability. Their excellent biocompatibility and chemical ver-satility make them powerful building blocks for the design of supramolecular nano-vectors (NVs). Thanks to their facility of functionalization, CDs are highly versatile and have found numerous applications across various fields. In this contest CD based NVs are currently explored as non-viral agents to transport and release siRNA. Recent studies suggest that self-assembled NVs based on CDs can improve the transfection and safety of siRNA delivery systems. This review provides a comprehensive overview of the most recent advances in the design of NVs based on CDs and their use for delivery of siRNA, discussing the ins and outs of structural differences and chemical functionalization.